Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease (original) (raw)

References

  1. Feldmann, M., Brennan, F.M. & Maini, R.N. Role of cytokines in rheumatoid arthritis. Ann. Rev. Immunol. 14, 397–440 (1996).
    Article CAS Google Scholar
  2. Mauri, C., Williams, R.O., Walmsley, M. & Feldmann, M. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur. J. Immunol. 26, 1511–1520 (1996).
    Article CAS Google Scholar
  3. Doncarli, A., Stasiuk, L.M., Fournier, C. & Abehsira-Amar, O. Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis. Eur. J. Immunol. 27, 1451–1460 (1997).
    Article CAS Google Scholar
  4. Joosten, L.A. et al. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Arthritis Rheum. 40, 249–260 (1997).
    Article CAS Google Scholar
  5. Walmsley, M. et al. Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum. 39, 495–503 (1996).
    Article CAS Google Scholar
  6. Horsfall, A.C. et al. Suppression of collagen-induced arthritis by continuous administration of interleukin-4. J. Immunol. 159, 5687–5696 (1997).
    CAS PubMed Google Scholar
  7. Pozo, D. et al. Immunobiology of vasoactive intestinal peptide (VIP). Immunol. Today 21, 7–11 (2000).
    Article CAS Google Scholar
  8. Delgado, M., Leceta, J., Gomariz, R.P. & Ganea, D. VIP and PACAP stimulate the induction of Th2 responses by upregulating B7.2 expression. J. Immunol. 163, 3629–3635 (1999).
    CAS PubMed Google Scholar
  9. Delgado, M., Munoz-Elias, E.J., Gomariz, R.P. & Ganea, D. VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNγ synthesis by T cells. J. Neuroimmunol. 96, 167–181 (1999).
    Article CAS Google Scholar
  10. Myers, L.K., Rosloniec, E.F., Cremer, M.A. & Kang, A.H. Collagen-induced arthritis, an animal model of autoimmunity. Life Sci. 61, 1861–1872 (1997).
    Article CAS Google Scholar
  11. Delgado, M., Munoz-Elias, E.J., Martinez, C., Gomariz, R.P. & Ganea, D. VIP and PACAP-38 modulate cytokine and nitric oxide production in peritoneal macrophages and macrophage cell lines. Ann. NY Acad. Sci. 897, 401–420 (1999).
    Article CAS Google Scholar
  12. O'Garra, A.O. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8, 275–287 (1998).
    Article CAS Google Scholar
  13. Seki, N. et al. Type II collagen-induced murine arthritis induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J. Immunol. 140, 1477–1487 (1988).
    CAS PubMed Google Scholar
  14. Taylor, P.C., Zyberk, C.P. & Maini, R.N. The role of the B cells in the adoptive transfer of collagen-induced arthritis from DBA/1 (H-2q) to SCID (H-2d) mice. Eur. J. Immunol. 25, 763–771 (1995).
    Article CAS Google Scholar
  15. Butler, D.M., Malfait, A.M., Maini, R.N., Brennan, F.M. & Feldmann, M. Anti-IL-12 and anti-TNF antibodies synergistically suppress the progression of murine collagen-induced arthritis. Eur. J. Immunol. 29, 2205–2212 (1999).
    Article CAS Google Scholar
  16. Malfait, A.M. et al. Blockade of interleukin 12 during the induction of collagen-induced arthritis markedly attenuates the severity of the arthritis. Clin. Exp. Immunol. 111, 377–386 (1998).
    Article CAS Google Scholar
  17. Brennan, F.M., Chantry, D., Jackson, A., Maini, R.N. & Feldmann, M. Inhibitory effect of TNFa antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2, 244–251 (1989).
    Article CAS Google Scholar
  18. Woessner, J.F. Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5, 2145–2154 (1991).
    Article CAS Google Scholar
  19. Gourlet, P. et al. Development of high affinity selective VIP1 receptor agonists. Peptides 18, 1539–1546 (1998).
    Article Google Scholar
  20. Xia, M., Sreedharan, S.P., Bolin, D.R., Gaufo, G.O. & Goetzl, E.J. Novel cyclic peptide agonist of high potency and selectivity for the type II vasoactive intestinal peptide receptor. J. Pharmacol. Exp. Ther. 281, 629–638 (1997).
    CAS PubMed Google Scholar
  21. Moro, O. & Lerner, E.A. Maxadilan, the vasodilator peptide from sand flies, is a specific pituitary adenylate cyclase activating peptide type I receptor agonist. J. Biol. Chem. 271, 966–974 (1996).
    Google Scholar
  22. Moreland, L.W. et al. Treatment of rheumatoid arthritis with a recombinant human TNF receptor (p65)-Fc fusion protein. N. Engl. J. Med. 337, 141–147 (1997).
    Article CAS Google Scholar
  23. Elliot, M.J. et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to TNFα. Arthritis Rheum. 36, 1681–1689 (1993).
    Article Google Scholar
  24. Watt, I. & Cobby, M. Recombinant human IL-1 receptor antagonist (rhIL-1ra) reduces the rate of joint erosion in rheumatoid arthritis (RA). Arthritis Rheum. 39, S123 (1996).
    Google Scholar
  25. Dinant, H.J. & Dijkmans, B.A.C. New therapeutic targets for rheumatoid arthritis. Pharm. World Sci. 21, 49–59 (1999).
    Article CAS Google Scholar
  26. Takeba, Y., Suzuki, N., Kaneko, A., Asai, T. & Sakane, T. Evidence for neural regulation of inflammatory synovial cell functions by secreting calcitonin gene-related peptide and vasoactive intestinal peptide in patients with rheumatoid arthritis. Arthritis Rheum. 42, 2418–2429 (1999)
    Article CAS Google Scholar
  27. Butler, D.M. et al. DBA/1 mice expressing the human TNFα transgene develop a severe, erosive arthritis: characterization of the cytokine cascade and cellular composition. J. Immunol. 159, 2867–2876 (1997).
    CAS PubMed Google Scholar
  28. Delgado, M. et al. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit TNFα transcriptional activation by regulating NF-κB and CREB/c-Jun. J. Biol. Chem. 273, 31427–31436 (1998).
    Article CAS Google Scholar
  29. Delgado, M., Munoz-Elias, E.J., Gomariz, R.P. & Ganea, D. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NFκB and IFN regulatory factor 1 activation. J. Immunol. 162, 4685–4696 (1999).
    CAS PubMed Google Scholar
  30. Espevik, T. & Nissen-Meyer, J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95, 99–105 (1989).
    Article Google Scholar
  31. Robbins, J.R., McGuire, P.G., Wehrle-Haller, B. & Rogers, S.L. Diminished matrix metalloproteinase 2 (MMP-2) in ectomesenchyme-derived tissue of the Patch mutant mouse: regulation of MMP-2 by PDGF and effects on mesenchymal cell migration. Dev. Biol. 212, 255–263 (1999).
    Article CAS Google Scholar
  32. Seetharaman, R. Mora, A.L., Nabozny, G., Boothby, M. & Chen, J. Essential role of T-cell NF-κB activation in collagen-induced arthritis. J. Immunol. 163, 1577–1583 (1999).
    CAS PubMed Google Scholar
  33. Kusaba, M., Honda, J., Fukuda, T. & Oizumi, K. Analysis of type 1 and type 2 T cells in synovial fluid and peripheral blood of patients with rheumatoid arthritis. J. Rheumatol. 25, 1466–1471 (1998)
    CAS PubMed Google Scholar

Download references